US flu vaccine's shortage ends in an oversupply
WASHINGTON -- In this year's bizarre flu season, it has come to this: Five months after health officials rationed vaccine because of a shortage, now there's a glut with one manufacturer and major distributors facing lost revenue totaling hundreds of millions of dollars. (Full article: 941 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





